India promised to protect intellectual property when it signed up to the World Trade Organization’s rules in 2005. Yet recent court decisions suggest the country still has a long way to go before ...

New Delhi: In a significant ruling interpreting the scope of patent exclusion for diagnostic methods in India, the Delhi High ...

A technical Tesla patent unexpectedly set off a political and cultural firestorm on X this week, not over artificial ...

India’s rising global presence is often associated with its booming tech sector. But in many poor countries, India’s role is that of a low-cost pharmacy. The country has become a leading supplier of ...

In a move fraught with political tension, Indian officials reversed course and granted a patent to Gilead Sciences for its Sovaldi hepatitis C treatment, handing the drug maker an unexpected victory ...

Abhishek Satish and Adarsh Warrier were students pursuing engineering in the south Indian town of Vellore when they founded Vicara - a startup that develops wearable technology devices. Soon after, ...

ZURICH (Reuters) - Roche Holding AG has decided not to pursue a patent application for its breast cancer drug Herceptin in India, the Swiss company said on Friday, as Western drugmakers come under ...

Kanchan Vadehra and Sharad Vadehra of Kan and Krishme discuss some of the unique features of the Indian patent system and tips to overcome those challenges Kanchan Vadehra: The first and most obvious ...

BENGALURU, India — India lags behind the world average in patent filings, with its total number of filings by residents being just three per million people in its population, compared with the world ...

India’s recently elected Prime Minister, Narendra Modi, will visit the U.S. later this month. One of the sticking points in the U.S.-India relationship is weakness in India’s laws governing ...

When is a decision on a patent application not a decision at all? When it runs counter to the powerful commercial and diplomatic forces that protect massively profitable pharmaceutical monopolies. Or ...

India’s patent office ruled in April that the patent on Valcyte, a Roche drug that prevents infection in transplant patients, is not valid in the country. With its decision, the patent office endorsed ...